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Summary
Objective: We sought to determine the molecular basis for the anticatabolic effects of mechanical signals on ﬁbrocartilage cells by studying the
expression of a variety of matrix metalloproteinases (MMPs). Furthermore, we examined whether the effects of biomechanical strain on MMP
gene expression are sustained.
Methods: Fibrochondrocytes from temporomandibular joint (TMJ) discs were exposed to dynamic tensile strain for various time intervals in the
presence of interleukin (IL)-1b. The regulation of the messenger RNA (mRNA) expression and synthesis of MMPs and tissue inhibitors of
MMPs (TIMPs) were examined by end-point and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) as well as Western
blot analysis.
Results: Fibrochondrocytes expressed mRNA for MMP-2, -3, -7, -8, -9, -11, -13, -14, -16, -17, and -19 as well as TIMP-1, -2, and -3, IL-1b
induced a signiﬁcant (P! 0.05) upregulation of mRNA for MMP-3, -7, -8, -9, -13, -16, -17, and -19. The IL-1b-stimulated upregulation of these
MMPs was signiﬁcantly (P! 0.05) abrogated by dynamic tensile strain. However, MMP-2, -11, -14, and TIMPs were not affected by either IL-
1b or tensile strain. Biomechanical strain also inhibited the IL-1b-stimulated protein synthesis of MMP-3, -7, -8, -9, -13, -16, and -17. Applica-
tion of mechanical strain for various time intervals during a 24-h incubation with IL-1b showed that the suppressive effects of mechanical
signals are sustained.
Conclusions: The data provide evidence that biomechanical signals can downregulate the catabolic activity of ﬁbrocartilage cells in an inﬂam-
matory environment by inhibiting the expression of a variety of MMPs. Furthermore, the matrix-protective effects of biomechanical signals are
sustained even in an inﬂammatory environment.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Mechanical strain, Fibrocartilage, TMJ, Matrix metalloproteinases.
OsteoArthritis and Cartilage (2006) 14, 264e272
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.joca.2005.09.005
International
Cartilage
Repair
SocietyIntroduction
Arthritis is an inﬂammatory disorder that is associated with
the loss of structure and function of the joint. The articular
inﬂammatory process causes synovial cells to proliferate
and synthesize proinﬂammatory and chemotactic cytokines,
thereby promoting the recruitment of additional immune
cells and perpetuating inﬂammation1,2. The altered balance
of inﬂammatory mediators and proteolytic fragments of the
extracellular matrix under inﬂammatory conditions changes
the levels of matrix-degrading enzymes, e.g., matrix metal-
loproteinases (MMPs) and tissue inhibitors of MMPs
(TIMPs), both required for normal tissue homeostasis and
remodeling3. MMPs not only mediate cartilage degradation
but also amplify immune response by proteolytic cleavage
and activation of cytokines. Additionally, their cleavage
products act as chemoattractants, thereby also serving as
proinﬂammatory signals4.
Current treatment concepts for arthritic patients are
based on our understanding of the pathological processes
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2005.26associated with arthritis. For the treatment of arthritis, non-
steroidal anti-inﬂammatory drugs (NSAIDs), corticosteroids,
and disease-modifying antirheumatic drugs (DMARDs) are
currently used. NSAIDs provide partial relief of pain and
stiffness but do not slow the progression of the disease.
Corticosteroids are suppressors of inﬂammation but, like
DMARDs and NSAIDs, have side effects which limit their
usefulness5e7.
One of the most promising approaches to successfully in-
hibit pain and catabolic processes in arthritis is exercise or
mechanical loading of inﬂamed joints. It has been demon-
strated that articular cartilage is better preserved in knees
treated with continuous passive motion than with immobili-
zation in arthritis8. Clinical applications of continuous pas-
sive motion in various joints have also produced very
satisfactory results9,10.
Little is known about the effects of mechanical loading on
knee menisci, or intervertebral and temporomandibular joint
(TMJ) discs, all of which consist of ﬁbrocartilage11. Fibrocar-
tilage is degraded by MMPs that are elevated in the synovi-
al ﬂuid of arthritic patients12. Fibrochondrocytes participate
in the inﬂammation-driven matrix degradation by production
and activation of MMPs13. In intervertebral discs, static
compression has been shown to induce MMP-2 activa-
tion14. Similarly, immobilization or dynamic compression af-
fects catabolic genes with an overall downregulation of
collagen and upregulation of aggrecanase, MMP-13, and4
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erates disc degeneration by reduction of proteoglycan syn-
thesis and increase in MMP-3 production16.
Interestingly, cyclic tensile strain (CTS) abolishes the in-
terleukin (IL)-1b-induced MMP-1 synthesis in rabbit ﬁbrocar-
tilage17. However, little is known about the regulation of other
MMPs by mechanical loading during inﬂammation in ﬁbro-
cartilage. It is also not clear whether biomechanical forces
can exert a sustained effect on the MMP expression in ﬁbro-
cartilaginous tissue. Therefore, in this report we sought to
determine if biomechanical strain suppresses the catabolic
phenotype of ﬁbrochondrocytes under inﬂamed conditions
by studying the expression of a variety of MMPs. Further-
more, we investigated whether the effects of biomechanical
strain are sustained under these conditions.
Materials and methods
CELL CULTURES
Fibrocartilage was harvested from TMJ discs of 10e12
week old SpragueeDawley rats (Harlan, Indianapolis, IN).
Discs were cleaned, minced and transferred onto macropo-
rous ﬁlters (Spectra/Mesh, Spectrum Laboratories, Rancho
Dominguez, CA) and placed in a digestion chamber. After in-
cubating with 0.2% trypsin for 10 min and 0.2% collagenase I
(Worthington, Lakewood, NJ) for 3 h, the cells were centri-
fuged and the pellet was resuspended in DMEM/F12
(Cellgro by Mediatech, Herndon, VA), supplemented with
10% FBS (Hyclone, Logan, UT), 1% Penicillin/Streptomy-
cin (Cellgro by Mediatech, Herndon, VA), and 1% L-Gluta-
mine (Gibco by Invitrogen, Grand Island, NY). Cells were
grown to 80e90% conﬂuence and used between third and
ﬁfth passage. Cells expressed messenger RNA (mRNA)
for aggrecan, biglycan, versican, and collagen type I.
APPLICATION OF CTS
Cells (5! 105/well) were seeded on collagen I-coated
BioFlex 6-well culture plates (Flexcell International Corp.,
Hillsborough, NC) and grown to 80% conﬂuence (7e8
days) in 5% CO2 and 37(C. One day before experiments,
the FBS concentration was decreased to 1%. To study
the anticatabolic effects of mechanical load on ﬁbrochon-
drocytes, BioFlex plates were placed onto the Loading Sta-
tions (Flexcell International Corp., Hillsborough, NC) andsubjected to CTS at 20% and 0.05 Hz in the presence or
absence of recombinant human interleukin-1b (1 ng/ml;
Calbiochem, CA).
To identify MMPs and TIMPs that are expressed and reg-
ulated by mechanical loading in inﬂamed ﬁbrocartilage,
cells were subjected to CTS in the presence and absence
of IL-1b for 4 and 24 h. In order to determine whether the
regulatory effect of mechanical loading on the MMP expres-
sion under inﬂamed conditions is sustained, cells were stim-
ulated with IL-1b for 24 h while being subjected to
mechanical strain only for the initial 1, 2, 4, 8, 12, 16, and
20 h. In addition, cells were incubated with IL-1b for 24,
36, and 48 h, while CTS was applied only for the ﬁrst 8 h
of the entire incubation time. Unstretched cells in the pres-
ence or absence of IL-1b were used as controls.
END-POINT REVERSE TRANSCRIPTASE-POLYMERASE
CHAIN REACTION (RT-PCR)
The screening for MMPs and TIMPs that are expressed in
ﬁbrochondrocytes was performed by end-point RT-PCR.
Primers speciﬁc for members of the MMP and TIMP families
(Table I) were designed with Primer Express (Applied
Biosystems, Foster City, CA). RNA was extracted from un-
treated controls and cells that were subjected to CTS and/
or IL-1b treatment for 24 h by an RNA extraction kit (Qiagen
Inc., Valencia, CA) according to the manufacturer’s recom-
mended protocols. A total of 1.0 mg of RNAwas reverse tran-
scribed with 200 U of Moloney murine leukemia virus
reverse transcriptase (Invitrogen, Carlsbad, CA) at 42(C
for 25 min followed by 65(C for 5 min. The cDNA was ampli-
ﬁed with 0.1 mg of speciﬁc primers in a reaction mixture
(PCR supermix, Invitrogen, Carlsbad, CA) containing Taq
DNA polymerase, TriseHCl, KCl, MgCl2, and dNTPs. Ampli-
ﬁcation was carried out for 30 cycles of 45 s at 94(C, 45 s at
59(C, and 60 s at 72(C by Mastercycler Gradient (Eppen-
dorf, Hamburg, Germany). The bands of ethidium bromide-
stained PCR products on agarose gels were visualized by
a Kodak Image Station 1000 (Eastman Kodak Company,
Rochester, NY).
REAL-TIME RT-PCR
In order to quantitatively analyze the regulatory effects of
IL-1b and/or CTS on the expression of MMPs that we hadTable I
Primer sequences for end-point RT-PCR
Sense (5#e3#) Antisense (5#e3#) Length (bp) Accession no.
MMP-2 CCC ATA CTT TAC TCG GAC CA TGA CCT TGA CCA GAA CAC CA 420 U65656
MMP-3 CTG GAA TGG TCT TGG CTC AT CTG ACT GCA TCG AAG GAC AA 370 NM_133523
MMP-7 GCA GAA GTT CTT CGG TTT GC TCT GCA GTC CCC CAA CTA AC 273 NM_012864
MMP-8 TGG TCT TCA GGC TGC TTA TG CTT GGA CAC TCC TTG GGA AT 146 AJ007288
MMP-9 CCA CCG AGC TAT CCA CTC AT GTC CGG TTT CAG CAT GTT TT 159 NM_031055
MMP-10 TGC TTT GTC CTT TGA TGC AG GTC TCG GGA AGC CTT TAT CC 398 NM_133514
MMP-11 GCC AGA TTT GGT TCT TCC AA AGT AGG CAT AGC CCT CAG CA 291 NM_012980
MMP-12 TGC AGC TGT CTT TGA TCC AC TCC AAT TGG TAG GCT CCT TG 204 NM_053963
MMP-13 CCC TCG AAC ACT CAA ATG GT GAG CTG CTT GTC CAG GTT TC 312 XM_343345
MMP-14 AGG GAC CCT CAT AGC TTG GT TAG GGC TCA TAT GCC CAA AG 190 NM_031056
MMP-16 CAG CTC TGG AAG AAG GTT GG GAG CTG CCT CTT GTT TGG TC 315 D85509
MMP-17 AGT TTG GCT ACC TCC CAC CT CCC TCC AAG AAA GGT TCC TC 252 XM_239639
MMP-19 GGC TTT CCC ATG AAA CTC AA TAG CTG CTG AGG GTT GGT CT 196 XM_222317
TIMP-1 GGT TCC CTG GCA TAA TCT GA GTC ATC GAG ACC CCA AGG TA 246 NM_053819
TIMP-2 GCA TCA CCC AGA AGA AGA GC TGA TGC AGG CAA AGA ACT TG 174 NM_021989
TIMP-3 CAC GGA AGC CTC TGA AAG TC GTA CCC GAA ATT GGA GAG CA 274 U27201
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formed by a Biorad iCycler iQ (Biorad, Hercules, CA) and
speciﬁc primers (Table II). Two microliters of cDNA as
a template was ampliﬁed with SYBR Green Supermix
(Biorad Hercules, CA) in a 25 ml reaction containing 1!
SYBR Green Supermix, 0.3 mM of each primer, and de-ion-
ized water. The mixture was heated initially at 95(C for
3 min and then followed by 40 cycles with denaturation at
95(C for 30 s, annealing at 59(C for 30 s, and extension
at 72(C for 30 s. Glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) was used as a housekeeping gene. Follow-
ing ampliﬁcation, melt curve protocols were performed to
ensure that primer-dimers or non-speciﬁc products had
been eliminated or minimized. To analyze the data obtained
by real-time PCR, the comparative threshold cycle (CT)
method was applied18,19. Brieﬂy, the amount of a target,
normalized to GAPDH, and relative to a calibrator (either
untreated sample or IL-1b-stimulated cells), is given by
2DDCT , where DDCTZDCT (sample)DCT (calibrator),
and DCT is the CT of the target gene subtracted from the
CT of GAPDH
18.
WESTERN BLOT ANALYSIS
In order to study whether the regulatory effects of IL-1b
and/or CTS on the expression of several MMPs are also re-
ﬂected at the protein level, Western blot analysis was per-
formed. MMPs were analyzed from whole lysate of cells
(2! 106) subjected to the regimens described above. Total
protein concentration was determined with a BCA Protein
Assay Reagent Kit (Pierce Biotechnology, Rockford, IL)
and a VICTOR3 plate reader (PerkineElmer, Boston,
MA) that measured the absorbance at 562 nm. Equal
amount of proteins in each lane was resolved on SDS-
10%-PAGE under reducing conditions. After electrophore-
sis, the proteins were electrotransferred to Immun-Blot
polyvinylidene diﬂuoride membranes (Bio-Rad Laborato-
ries, Hercules, CA). The membranes were blocked with
5% nonfat milk and probed with goat polyclonal anti-rat
MMP-3, -7, -8, -9, -13, or -16 antibodies or with a rabbit
polyclonal anti-rat MMP-17 antibody (Santa Cruz Biotech-
nology, CA). These antibodies recognize pro- and active
forms of MMPs (Santa Cruz Biotechnology, CA). Horserad-
ish peroxidase (HRP) conjugated donkey anti-goat immu-
noglobulin G (IgG) or HRP-conjugated donkey anti-rabbit
IgG were applied for detection (Chemicon International, Te-
mecula, CA). To conﬁrm equal input in each lane, blotswere also probed with a mouse monoclonal anti-rat b-actin
antibody (Abcam, Cambridge, MA) and an HRP-conjugated
donkey anti-mouse IgG. Lightening Chemiluminescence re-
agent (PerkineElmer Life Sciences, Boston, MA) was used
as substrate for HRP.
STATISTICAL ANALYSIS
The SPSS 13.0 software (SPSS Inc., Chicago, IL) was
used for statistical analysis. For quantitative analysis of
the mRNA expression, mean values and standard errors
of the mean (S.E.M.) were calculated (nZ 6/group) and a sta-
tistical analysis was performed for each experiment. Each
experiment was performed at least three times. To deter-
mine whether signiﬁcant differences exist between untreated
cells, IL-1b-stimulated cells, cells subjected to CTS, and
IL-1b-stimulated cells simultaneously subjected to CTS,
One-Way analysis of variance (ANOVA) and the post hoc
multiple comparison Tukey’s test were applied. To compare
different groups of stretched IL-1b-treated cells with un-
stretched IL-1b-treated cells, One-Way ANOVA and the
post hoc multiple comparison Dunnett’s test were used. Dif-
ferences were regarded as statistically signiﬁcant at values
of P! 0.05.
Results
FIBROCHONDROCYTES EXPRESS A VARIETY
OF MMPS AND TIMPS
First, we sought to determine what members of the MMP
and TIMP families are expressed in ﬁbrocartilage. Fibro-
chondrocytes constitutively expressed mRNA for MMP-2,
-3, -7, -8, -9, -11, -13, -14, -16, -17, and -19 as well as
TIMP-1, -2, and -3. However, untreated cells did not ex-
press MMP-10 and -12 mRNA [Fig. 1(A)]. Furthermore, ex-
pression of both MMPs could also not be observed when
cells were exposed to IL-1b and/or CTS for 24 h (data not
shown).
MECHANICAL SIGNALS REGULATE MMP-9 AND -13
EXPRESSION
As MMP-9 and -13 play a key role in cartilage degrada-
tion associated with arthritis, we ﬁrst sought to determine
whether dynamic tensile strain modulates the expressionTable II
Primer sequences for real-time RT-PCR
Sense (5#e3#) Antisense (5#e3#) Length (bp) Accession no.
MMP-2 TGG GGG AGA TTC TCA CTT TG CCA TCA GCG TTC CCA TAC TT 87 U65656
MMP-3 TGG GAA GCC AGT GGA AAT G CCA TGC AAT GGG TAG GAT GAG 81 NM_133523
MMP-7 TCG GCG GAG ATG CTC ACT TGG CAA CAA ACA GGA AGT TCA C 81 NM_012864
MMP-8 ACC TAC GAA AAT TCT ACC ACT TAC CAA CCT TAA GCT TCT CGG CAA TCA 81 AJ007288
MMP-9 TGC TCC TGG CTC TAG GCT AC TTG GAG GTT TTC AGG TCT CG 88 NM_031055
MMP-11 ACT TTC CGC TGA CAA CAC CT GAA GCC CAG GTC CAC AAA TA 85 NM_012980
MMP-13 CTG ACC TGG GAT TTC CAA AA ACA CGT GGT TCC CTG AGA AG 90 XM_343345
MMP-14 TGG GGT CAT CTG CTT CTC TT TAG GGC TCA TAT GCC CAA AG 90 NM_031056
MMP-16 GAG CTC GTC CAT CCG TTG AG GAA CGA TGC ACG AAA TCC AA 85 D85509
MMP-17 TCA TGT ACT ACG CCC TCA AAG TCT ATC TGG ATG TCC GCC ATG TT 85 XM_239639
MMP-19 GGA AAC AAG GTG TGG CGG TAT CAT CTA GGT TGG GTT CCA CTC TGT 85 XM_222317
TIMP-1 CTG AGA AGG GCT ACC AGA GC GTC ATC GAG ACC CCA AGG TA 88 NM_053819
TIMP-2 AGG ACC TGA CAA GGA CAT CG TTC TTT CCT CCA ACG TCC AG 84 NM_021989
TIMP-3 TAC ACA GGG CTG TGC AAC TT CCA GGT GGT AGC GGT AAT TG 85 U27201
GAPDH CTC AAC TAC ATG GTC TAC ATG TTC CA CTT CCC ATT CTC AGC CTT GAC T 81 X02231
267Osteoarthritis and Cartilage Vol. 14, No. 3Fig. 1. (A) Constitutive expression of mRNA for MMPs and TIMPs in ﬁbrochondrocytes, as analyzed by end-point RT-PCR. Representative
data from one of three experiments are shown. (B) MMP-9 and (C) MMP-13mRNAexpression in ﬁbrochondrocytes at 4 and 24 h, as determined
by real-time PCR. Cells were treated with 1 ng/ml of IL-1b and/or subjected to CTS at 20% and 0.05 Hz. Results are shown as meansG S.E.M.
(nZ 6/group). For statistical analysis, the One-Way ANOVA and the post hoc multiple comparison Tukey’s test were employed. *Signiﬁcantly
(P! 0.05) different from all other groups including control, ysigniﬁcantly (P! 0.05) different from IL-1b-treated cells, zsigniﬁcantly (P! 0.05)
different from IL-1b-treated cells in the presence and absence of CTS. Representative data from one of four experiments are shown. (D) Protein
synthesis of MMP-3, -7, -8, -9, -13, -16, and -17 at 24 h, as determined by Western blot analysis. Cells were treated with 1 ng/ml of IL-1b and/or
subjected to CTS at 20% and 0.05 Hz for 24 h. Representative gels from one of three experiments are shown.of these MMPs in ﬁbrochondrocytes under inﬂammatory
conditions. IL-1b that was used as an inﬂammatory agent,
signiﬁcantly (P! 0.05) upregulated the expression of
MMP-9 and -13 at 4 and 24 h, as demonstrated by real-
time PCR. However, when IL-1b-treated cells were simul-
taneously subjected to CTS, the IL-1b-induced upregula-
tion of MMP-9 and -13 was signiﬁcantly (P! 0.05)
inhibited at both time points [Fig. 1(B, C)]. Western blot
analysis revealed that the IL-1b-stimulated upregulation
of mRNA for both MMPs was paralleled by their protein
synthesis at 24 h. Figure 1(D) shows the presence of
bands at approximately 82 kDa and 48 kDa, representing
active forms of MMP-9 and -13. More importantly, the IL-
1b-stimulated synthesis of both MMPs was inhibited by
CTS [Fig. 1(D)].CTS ALSO AFFECTS EXPRESSION OF MMP-3, -7, -8, -16, -17,
AND -19
Since ﬁbrocartilage cells also express other members
of the MMP and TIMP families [Fig. 1(A)], we studied the ef-
fect of CTS on their expression in IL-1b-treated ﬁbrochon-
drocytes. IL-1b signiﬁcantly (P! 0.05) upregulated the
constitutive mRNA expression for MMP-3, -7, -8, -16, -17,
and -19. Nevertheless, the upregulation of the mRNA ex-
pression for these MMPs was only observed when cells
were exposed to IL-1b for 24 h [Fig. 2(AeF)] but not after
4 h (data not shown). Interestingly, CTS also signiﬁcantly
(P! 0.05) suppressed the IL-1b-induced upregulation of
these MMPs when examined at 24 h [Fig. 2(AeF)]. As dem-
onstrated by Western blot analysis, the IL-1b-induced upre-
gulation of mRNA for these MMPs was paralleled by an
268 J. Deschner et al.: Regulation of MMP expression in rat ﬁbrochondrocytesincrease in the synthesis of their proteins. Furthermore, the
IL-1b-stimulated synthesis of these MMPs was inhibited by
CTS. Protein bands at approximately 45 kDa for MMP-3,
20 kDa for MMP-7, 50 kDa for MMP-8, 55 kDa for MMP-
16, and 67 kDa for MMP-17 were observed, representing
active forms of these MMPs [Fig. 1(D)].
Interestingly, MMP-2, -11, and -14 as well as TIMPs were
not regulated by IL-1b and/or CTS at either 4 or 24 h (data
not shown).
SUPPRESSION OF IL-1-INDUCED MMP-9 AND -13 EXPRESSION
IS SUSTAINED AFTER REMOVAL OF CTS
Next, we sought to determine whether the inhibitory effect
of CTS on the MMP expression in the presence of IL-1b is
sustained. Since MMP-9 and -13 are major key players in
arthritic diseases, we focused on the expression of these
MMPs. Cells were stimulated with IL-1b for 24 h while being
subjected to mechanical strain either only for the initial 1, 2,
4, 8, 12, 16, and 20 h or for the entire 24-h incubation time.
Application of CTS for 1 h was not sufﬁcient to inhibit the IL-
1b-induced MMP-9 expression when examined 23 h later.
Nevertheless, exposure of cells to CTS for 2, 4, and 8 hsigniﬁcantly (P! 0.05) inhibited the IL-1b-stimulated
MMP-9 expression. Interestingly, CTS applied for 12 h or
16 h did not induce a signiﬁcant decrease in the IL-1b-in-
duced MMP-9 expression, whereas a signiﬁcantly
(P! 0.05) inhibitory effect of CTS was observed again
when CTS was applied for 20 h or 24 h [Fig. 3(A)]. Applica-
tion of CTS for 1, 2, 4, and 8 h also signiﬁcantly (P! 0.05)
reduced the IL-1b-stimulated MMP-13 expression. Similar
to MMP-9, IL-1b-induced MMP-13 expression was not sig-
niﬁcantly decreased when CTS was applied for 16 h. How-
ever, for 20 and 24 h of CTS application a signiﬁcant
(P! 0.05) inhibition of the IL-1b-induced MMP-13 expres-
sion was again observed [Fig. 3(B)].
Since CTS applied only for the initial 8 h during the entire
24-h incubation with IL-1b had a profound and sustained
suppressive effect on MMP-9 and -13, we wondered how
long this effect would be sustained. Cells were incubated
with IL-1b for 24, 36, and 48 h while CTS was applied
only for the initial 8 h. The inhibition of the IL-1b-stimulated
mRNA expression for MMP-9 and -13 was statistically sig-
niﬁcant (P! 0.05) at 24 and 36 h [Fig. 3(C, D)]. However,
no signiﬁcant suppression by CTS was observed at 48 h
[Fig. 3(C, D)].Fig. 2. Expression of mRNA for (A) MMP-3, (B) MMP-7, (C) MMP-8, (D) MMP-16, (E) MMP-17, and (F) MMP-19 in ﬁbrochondrocytes at 24 h,
as determined by real-time PCR. Cells were treated with 1 ng/ml of IL-1b and/or subjected to CTS at 20% and 0.05 Hz. Results are shown as
meansG S.E.M. (nZ 6/group). For statistical analysis, the One-Way ANOVA and the post hoc multiple comparison Tukey’s test were em-
ployed. *Signiﬁcantly (P! 0.05) different from all other groups including control, ysigniﬁcantly (P! 0.05) different from IL-1b-treated cells,
zsigniﬁcantly (P! 0.05) different from IL-1b-treated cells in the presence and absence of CTS. Representative data from one of four experi-
ments are shown.
269Osteoarthritis and Cartilage Vol. 14, No. 3Fig. 3. Expression of mRNA for (A) MMP-9 and (B) MMP-13 at 24 h, as analyzed by real-time RT-PCR. Fibrochondrocytes were stimulated
with IL-1b for 24 h while being subjected to CTS (20%, 0.05 Hz) either only for the initial 1, 2, 4, 8, 12, 16, and 20 h or for the entire 24 h-
interval. Results are shown as meansG S.E.M. (nZ 6/group). For statistical analysis, the One-Way ANOVA and the post hoc multiple com-
parison Dunnett’s test were employed. *Signiﬁcantly (P! 0.05) different from unstretched IL-1b-treated cells. Representative data from one of
three experiments are shown. (C) MMP-9 and (D) MMP-13 mRNA expression at 24, 36, and 48 h. Cells were incubated with 1 ng/ml of IL-1b
for 24, 36, and 48 h, respectively, while CTS (20%, 0.05 Hz) was applied only for the initial 8 h of the entire incubation time. Results are shown
as meansG S.E.M., (nZ 6/group). For statistical analysis, the One-Way ANOVA and the post hoc multiple comparison Dunnett’s test were
employed. *Signiﬁcantly (P! 0.05) different from unstretched IL-1b-treated cells. Representative data from one of four experiments are
shown.Discussion
Our data provide evidence that biomechanical strain
downregulates the expression of MMPs in ﬁbrocartilage
cells in an inﬂammatory environment. This suggests that
mechanical loading is not only critical to ﬁbrocartilage ho-
meostasis and remodeling but also to prevent extracellular
matrix degradation in arthritic diseases. MMPs are zinc-de-
pendent endopeptidases which can cleave constituents of
the extracellular matrix of ﬁbrocartilage as well as non-ma-
trix proteins. Increased intraarticular levels of MMPs, in re-
sponse to proinﬂammatory cytokines such as IL-1b, are
hallmarks of arthritis4,20. We have shown that IL-1b not
only induces upregulation of MMPs like MMP-3, -7, -8, -9
and -13 that are known to be present in ﬁbrocartilage
but also MMP-19 and membrane-type MMPs (MMP-16
and -17) that have not been as yet identiﬁed in this tissue.This study conﬁrms the role of IL-1b as a critical key proca-
tabolic mediator in arthritic diseases. More importantly,
these actions of IL-1b are effectively abolished by CTS,
which provide strong evidence for a possible role of CTS
as an anticatabolic signal in arthritic diseases.
MMP-9 is a matrix-degrading MMP that increases with
the progression of arthritis12. MMP-9 knockouts have milder
arthritis proving a detrimental role of MMP-921. Similarly,
MMP-13 has a crucial role in cartilage degradation and sub-
chondral bone resorption by its ability to cleave collagen,
gelatin, and aggrecan, as well as to activate proteolytic en-
zymes22e24. The observations that intraarticular injections
of MMP-13 induce collagen cleavage in the joints25, trans-
genic mice overexpressing MMP-13 show cartilage degra-
dation26, and MMP-13 is found in synovial ﬂuids of
arthritic patients12 further suggest its importance in cartilage
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ical signals generated by CTS may be extremely signiﬁcant
in matrix protection by abrogating the synthesis of both
these key enzymes involved in cartilage destruction.
MMP-3 associated tissue destruction is due to its ability
to cleave collagen, gelatin, proteoglycans, and glycopro-
teins27. Furthermore, MMP-3 has an established role as
an activator of other MMPs, such as MMP-1, -7, -8, -9,
and -1324. The upregulation of MMP-3 by IL-1b is well docu-
mented28. Our data revealed that CTS can suppress the IL-
1b-induced synthesis of this MMP. While little is known
about MMP-7, its role in cartilage destruction involves its
ability to cleave a variety of extracellular matrix constituents,
to activate gelatinases, and to function as a pro-tumor ne-
crosis factor-a (pro-TNF-a) convertase29. This enzyme
was also upregulated by IL-1b and downregulated by the
actions of CTS on ﬁbrochondrocytes in the present study.
MMP-8 has the ability to cleave collagen, gelatin, and other
matrix molecules. However, the involvement of MMP-8 in
enhanced cartilage matrix breakdown in osteoarthritic carti-
lage degeneration is debated30. Interestingly, our data show
that MMP-8 is also produced by ﬁbrochondrocytes and reg-
ulated by IL-1b and biomechanical signals. Membrane-an-
chored MMP-16 and -17 are also increased in the
synovial membrane of arthritic patients31,32. MMP-16 not
only cleaves collagen, gelatin, casein, ﬁbronectin, and acti-
vates gelatinase but also cleaves focal adhesion kinase33.
MMP-17 has a role in angiogenesis, gelatin degradation,
and cleavage of pro-TNF-a, thus also functioning as a proin-
ﬂammatory mediator34,35. MMP-19 is widely expressed in
quiescent conditions36 and is involved in matrix degrada-
tion, angiogenesis, neovasculation, and lymphocyte extrav-
asation. It is found in blood vessel walls of inﬂamed
synovium of rheumatoid arthritis patients37. The present
study provides evidence that CTS suppresses IL-1b-in-
duced expression of MMP-16, -17, and -19.
This study also showed that the suppression of the IL-1b-
upregulated mRNA expression by CTS is also reﬂected at
the protein level for MMP-3, -7, -8, -9, -13, -16, and -17.
Since an antibody recognizing rat MMP-19 is commercially
unavailable, the examination of this MMP could not be per-
formed. Interestingly, CTS alone decreased the constitutive
protein synthesis of several MMPs but did not change their
mRNA expression, indicating that CTS might also regulate
MMPs at the post-transcriptional level. In view of the fact
that mechanical signals were able to regulate the expres-
sion and protein synthesis of these MMPs in an inﬂamma-
tory environment, the signiﬁcance of these signals should
not be underestimated.
Interestingly, MMP-2, -11, and -14 were constitutively ex-
pressed in ﬁbrochondrocytes but were not affected by IL-1b
and/or CTS. Little is known about the actions of MMP-11
and -14 or their involvement in arthritis. MMP-2 is widely ex-
pressed by most cell types but appears to be only marginally
induced or repressed by growth factors and cytokines38.
The same may also apply to its regulation by CTS.
The reason why the mRNA expression for some MMPs
was signiﬁcantly upregulated by IL-1b at 4 h but not for others
until 24 h has yet to be elucidated. Although not studied here,
it might be that the effect of IL-1b on those MMPs that were
not signiﬁcantly changed until 24 h was rather indirect.
This study also demonstrated that all three members of
the TIMP family are synthesized by ﬁbrochondrocytes.
However, neither IL-1b nor CTS affected their expression.
This is in contrast to our earlier ﬁndings in rabbits17 where
mechanical forces upregulated TIMP-2. Species-related dif-
ferences might be responsible for these ﬁndings.Little is known about the regulatory role of mechanical
strain in ﬁbrocartilage. Fibrocartilage of the human TMJ is
markedly thinner in edentate individuals where occlusal
forces are substantially reduced, suggesting that mainte-
nance of the ﬁbrocartilage depends on intermittent mechan-
ical loading39. Furthermore, high and low hydrostatic
pressures are suggested to accelerate intervertebral disc
degeneration, whereas physiologic levels act as an anabolic
signal for stimulation of proteoglycan synthesis and TIMP-1
production16. In accordance, tensile strain of physiological
levels inhibits MMP-1 synthesis and promotes TIMP-2 pro-
duction in rabbit TMJ disc cells17. These ﬁndings indicate
that there are distinct thresholds of mechanical signals for
modeling and remodeling on the one side, and tissue
destruction and cell death on the other side40. In the present
study ﬁbrochondrocytes of the TMJ dics were subjected to
CTS at a relatively high strain. We found that CTS at this
strain was most efﬁcient in counteracting the effects of
inﬂammatory mediators on rat ﬁbrochondrocytes, even if
CTS at lower strain also had an inhibitory effect (unpub-
lished data). Several investigators have sought to deter-
mine what tensile stress ﬁbrochondrocytes of the human
TMJ discs experience during mandibular movements. By
ﬁnite element analysis it has been demonstrated that nor-
mal motion results in relatively high stresses deep in the
TMJ joint41. Interestingly, almost four times higher tensile
stresses are found in discs when compared to condyles42.
Furthermore, large disc deformations occur for relatively
small joint loads43. Although these studies suggest that rel-
atively high strain can be observed, the physiological strain
that disc cells of the rat TMJ experience during joint loading
has yet to be determined. The present in vitro study on the
effects of mechanical signals on the MMP expression is the
ﬁrst step in understanding the actions of mechanical load-
ing. Whether similar forces are effective in regulating inﬂam-
mation in vivo is yet to be determined.
While our data demonstrate that mechanical signals sup-
press MMP expression in the presence of an inﬂammatory
stimulus, it was not clear whether these responses are sus-
tained after removal of CTS. Intriguingly, the suppressive
effect of biomechanical strain on MMPs was sustained
even if CTS was applied only for the initial 2 h of the 24-h
incubation with IL-1b. In general, the longer the cells were
subjected to CTS the higher the suppressive effect. Surpris-
ingly, the MMP suppression was less after exposure of cells
to CTS for 12 or 16 h when compared to other time points.
Interestingly, we have observed the same cell response in
similar experiments on articular chondrocytes and meniscal
cells (unpublished observations). However, the mechanism
behind this observation is unclear. More importantly, the
suppressive effects of biomechanical strain applied for the
initial 8 h were recognizable until 36 h. Taken together,
these ﬁndings emphasize that the anticatabolic effects of
biomechanical strain are sustained and this information
may be relevant for a clinical application. Especially, in
view of the fact that mechanical load or motion as a thera-
peutic measure is difﬁcult to apply in patients over long pe-
riods of time.
This in vitro study provides evidence that biomechanical
strain can downregulate the catabolic phenotype of ﬁbrocar-
tilage cells in an inﬂammatory environment by inhibiting the
expression and synthesis of a variety of MMPs. Further-
more, this study showed that the matrix-protective effect
of biomechanical loading under an inﬂammatory environ-
ment is sustained. Thus it can be concluded that the effects
of mechanical loading/motion are critical to prevent extra-
cellular matrix degradation in inﬂammatory diseases and
271Osteoarthritis and Cartilage Vol. 14, No. 3might have a potential application in the treatment of pa-
tients afﬂicted with arthritic diseases.
Acknowledgments
The authors are thankful to Dr F.M. Beck for his valuable
advise on the statistical analysis. This study was supported
by grants from the National Institutes of Health: DE15399,
DE13799, and AT000646.
References
1. Sweeney SE, Firestein GS. Rheumatoid arthritis: regu-
lation of synovial inﬂammation. Int J Biochem Cell Biol
2004;36:372e8.
2. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role
of cytokines in osteoarthritis pathophysiology. Bio-
rheology 2002;39:237e46.
3. Iannone F, Lapadula G. The pathophysiology of osteo-
arthritis. Aging Clin Exp Res 2003;15:364e72.
4. Mohammed FF, Smookler DS, Khokha R. Metallopro-
teinases, inﬂammation, and rheumatoid arthritis. Ann
Rheum Dis 2003;62(Suppl 2):ii43e7.
5. O’Dell JR. Therapeutic strategies for rheumatoid arthri-
tis. N Engl J Med 2004;350:2591e602.
6. Trippel SB. The unmet anti-inﬂammatory needs in or-
thopedics. Am J Orthop 1999;28:3e7.
7. Schurman DJ, Smith RL. Osteoarthritis: current treat-
ment and future prospects for surgical, medical, and
biologic intervention. Clin Orthop Relat Res 2004;
427(Suppl):S183e9.
8. Kim HK, Kerr RG, Cruz TF, Salter RB. Effects of contin-
uous passive motion and immobilization on synovitis
and cartilage degradation in antigen induced arthritis.
J Rheumatol 1995;22:1714e21.
9. Salter RB. History of rest and motion and the scientiﬁc
basis for early continuous passive motion. Hand Clin
1996;12:1e11.
10. Johnson DP, Eastwood DM. Beneﬁcial effects of con-
tinuous passive motion after total condylar knee ar-
throplasty. Ann R Coll Surg Engl 1992;74:412e6.
11. Benjamin M, Ralphs JR. Biology of ﬁbrocartilage cells.
Int Rev Cytol 2004;233:1e45.
12. Yoshihara Y, Nakamura H, Obata K, Yamada H,
Hayakawa T, Fujikawa K, et al. Matrix metalloprotei-
nases and tissue inhibitors of metalloproteinases in
synovial ﬂuids from patients with rheumatoid arthritis
or osteoarthritis. Ann Rheum Dis 2000;59:455e61.
13. Roberts S, Caterson B, Menage J, Evans EH,
Jaffray DC, Eisenstein SM. Matrix metalloproteinases
and aggrecanase: their role in disorders of the human
intervertebral disc. Spine 2000;25:3005e13.
14. Hsieh AH, Lotz JC. Prolonged spinal loading induces
matrix metalloproteinase-2 activation in intervertebral
discs. Spine 2003;28:1781e8.
15. MacLean JJ, Lee CR, Grad S, Ito K, Alini M, Iatridis JC.
Effects of immobilization and dynamic compression on
intervertebral disc cell gene expression in vivo. Spine
2003;28:973e81.
16. Handa T, Ishihara H, Ohshima H, Osada R, Tsuji H,
Obata K. Effects of hydrostatic pressure on matrix syn-
thesis and matrix metalloproteinase production in the
human lumbar intervertebral disc. Spine 1997;22:
1085e91.17. Agarwal S, Long P, Gassner R, Piesco NP, Buckley MJ.
Cyclic tensile strain suppresses catabolic effects of in-
terleukin-1beta in ﬁbrochondrocytes from the temporo-
mandibular joint. Arthritis Rheum 2001;44:608e17.
18. Giulietti A, Overbergh L, Valckx D, Decallonne B,
Bouillon R, Mathieu C. An overview of real-time quan-
titative PCR: applications to quantify cytokine gene ex-
pression. Methods 2001;25:386e401.
19. Livak KJ, Schmittgen TD. Analysis of relative gene ex-
pression data using real-time quantitative PCR and
the 2(Delta Delta C(T)) method. Methods 2001;25:
402e8.
20. Martel-Pelletier J, Welsch DJ, Pelletier JP. Metallopro-
teases and inhibitors in arthritic diseases. Best Pract
Res Clin Rheumatol 2001;15:805e29.
21. Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S,
Suzuki R. The role of matrix metalloproteinase-2 and
matrix metalloproteinase-9 in antibody-induced arthri-
tis. J Immunol 2002;169:2643e7.
22. Mitchell PG, Magna HA, Reeves LM, Lopresti-
Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, ex-
pression, and type II collagenolytic activity of matrix
metalloproteinase-13 from human osteoarthritic carti-
lage. J Clin Invest 1996;97:761e8.
23. Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ.
Degradation of cartilage aggrecan by collagenase-3
(MMP-13). FEBS Lett 1996;380:17e20.
24. Dreier R, Grassel S, Fuchs S, Schaumburger J,
Bruckner P. Pro-MMP-9 is a speciﬁc macrophage
product and is activated by osteoarthritic chondrocytes
via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp Cell
Res 2004;297:303e12.
25. Otterness IG, Bliven ML, Eskra JD, te Koppele JM,
Stukenbrok HA, Milici AJ. Cartilage damage after intra-
articular exposure to collagenase 3. Osteoarthritis
Cartilage 2000;8:366e73.
26. Neuhold LA, Killar L, Zhao W, Sung ML, Warner L,
Kulik J, et al. Postnatal expression in hyaline cartilage
of constitutively active human collagenase-3 (MMP-
13) induces osteoarthritis in mice. J Clin Invest 2001;
107:35e44.
27. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A,
Nakanishi I, et al. Localization of matrix metalloprotei-
nase 3 (stromelysin) in osteoarthritic cartilage and
synovium. Lab Invest 1992;66:680e90.
28. Schrier DJ, Flory CM, Finkel M, Kuchera SL, Lesch ME,
Jacobson PB. The effects of the phospholipase A2 in-
hibitor, manoalide, on cartilage degradation, stromely-
sin expression, and synovial ﬂuid cell count induced
by intraarticular injection of human recombinant inter-
leukin-1 alpha in the rabbit. Arthritis Rheum 1996;39:
1292e9.
29. Gearing AJ, Beckett P, Christodoulou M, Churchill M,
Clements JM, Crimmin M, et al. Matrix metalloprotei-
nases and processing of pro-TNF-alpha. J Leukoc
Biol 1995;57:774e7.
30. StremmeS, Duerr S, Bau B, Schmid E, Aigner T. MMP-8
is only a minor gene product of human adult articular
chondrocytes of the knee. Clin Exp Rheumatol 2003;
21:205e9.
31. Pap T, Shigeyama Y, Kuchen S, Fernihough JK,
Simmen B, Gay RE, et al. Differential expression pat-
tern of membrane-type matrix metalloproteinases in
rheumatoid arthritis. Arthritis Rheum 2000;43:
1226e32.
32. Yamanaka H, Makino K, Takizawa M, Nakamura H,
Fujimoto N, Moriya H, et al. Expression and tissue
272 J. Deschner et al.: Regulation of MMP expression in rat ﬁbrochondrocyteslocalization of membrane-types 1, 2, and 3 matrix met-
alloproteinases in rheumatoid synovium. Lab Invest
2000;80:677e87.
33. Shofuda T, Shofuda K, Ferri N, Kenagy RD,
Raines EW, Clowes AW. Cleavage of focal adhesion
kinase in vascular smooth muscle cells overexpress-
ing membrane-type matrix metalloproteinases. Arte-
rioscler Thromb Vasc Biol 2004;24:839e44.
34. Plaisier M, Kapiteijn K, Koolwijk P, Fijten C,
Hanemaaijer R, Grimbergen JM, et al. Involvement
of membrane-type matrix metalloproteinases (MT-
MMPs) in capillary tube formation by human endome-
trial microvascular endothelial cells: role of MT3-MMP.
J Clin Endocrinol Metab 2004;89:5828e36.
35. English WR, Puente XS, Freije JM, Knauper V,
Amour A, Merryweather A, et al. Membrane type 4
matrix metalloproteinase (MMP17) has tumor necro-
sis factor-alpha convertase activity but does not
activate pro-MMP2. J Biol Chem 2000;275:
14046e55.
36. Sedlacek R, Mauch S, Kolb B, Schatzlein C, Eibel H,
Peter HH, et al. Matrix metalloproteinase MMP-19
(RASI-1) is expressed on the surface of activated pe-
ripheral blood mononuclear cells and is detected as an
autoantigen in rheumatoid arthritis. Immunobiology
1998;198:408e23.37. Kolb C, Mauch S, Peter HH, Krawinkel U, Sedlacek R.
The matrix metalloproteinase RASI-1 is expressed in
synovial blood vessels of a rheumatoid arthritis
patient. Immunol Lett 1997;57:83e8.
38. Ijima Y, Kobayashi M, Kubota E. Role of interleukin-1 in
induction of matrix metalloproteinases synthesized by
rat temporomandibular joint chondrocytes and disc
cells. Eur J Oral Sci 2001;109:50e9.
39. Taddei C, Frank RM, Cahen PM. Effects of complete
denture wearing on temporomandibular joints: a histo-
morphometric study. J Prosthet Dent 1991;65:692e8.
40. Milentijevic D, Torzilli PA. Inﬂuence of stress rate on
water loss, matrix deformation and chondrocytes via-
bility in impacted articular cartilage. J Biomech 2005;
38:493e502.
41. DeVocht JW, Goel VK, Zeitler DL, Lew D. A study of the
control of disc movement within the temporomandibu-
lar joint using the ﬁnite element technique. J Oral Max-
illofac Surg 1996;54:1431e7, discussion 1437e1438.
42. Chen J, Akyuz U, Xu L, Pidaparti RM. Stress analysis of
the human temporomandibular joint. Med Eng Phys
1998;20:565e72.
43. Beek M, Koolstra JH, van Ruijven LJ, van Eijden TM.
Three-dimensional ﬁnite element analysis of the hu-
man temporomandibular joint disc. J Biomech 2000;
33:307e16.
